Dominic Clark

Dominic Clark
Industry Programme Manager

Dominic is the Manager of the EMBL-EBI Industry Programme - a global pre-competitive alliance of over 20 major life sciences companies and EMBL-EBI. He is responsible for planning global business development activities and the delivery of the Programme's activities, including planning and moderation of knowledge exchange workshops on topics prioritised by members. 

Prior to joining EMBL-EBI, Dominic worked for Sagentia Ltd as a Managing Consultant with a focus on life sciences, pharmaceuticals and due diligence.  This includes a four-year secondment to EMBL-EBI during which he managed a number of strategic projects and initiatives, including the initial stages of the ELIXIR preparatory phase project.

Before joining Sagentia Ltd, Dominic was Vice President of Informatics and IT at Pharmagene Ltd and was part of the management team during the flotation on the London Stock Exchange in 2001.

He spent five years at GlaxoWellcome (now GSK) in senior management roles including Principle Scientist, UK Bioinformatics Manager, Programme Manager Global R&D Infrastructure and Global Internet & Intranet Services Manager.

His initial research was conducted at the Imperial Cancer Research Fund (now CRUK) where he published numerous papers and managed projects in the areas of Medical informatics, AI, logic programming, computational biology and bioinformatics.

Dominic holds a PhD in Medical Informatics/AI from the University of Wales Institute of Science and Technology and a postgraduate diploma in IT Project management (OU). He is a founding director of the International Society for Computational Biology.

ORCID iD: 0000-0002-2227-8834

Tel:+44 (0)1223 492 575 / Fax:+44 (0)1223 494 468

Industry Programme office

Since 1996 the Industry Programme has provided on-going and regular contact with key stakeholder groups. The programme is subscription-funded and primarily represents larger companies. The Industry Programme supports and encourages precompetitive projects by hosting regular strategy meetings and knowledge-exchange workshops. Outputs from pre-competitive projects are made publicly available, thereby sharing the benefits with interested parties in all EMBL member states. The programme serves as an interface between EMBL-EBI and the Innovative Medicines Initiative (IMI), the Pistoia Alliance and other precompetitive initiatives and encourages the involvement of industry in ELIXIR, the emerging pan-European infrastructure for biological information.



Team members

  • Edgardo Ferran
  • Hall Matthew
  • Euphemia Mutasa-Gottgens
  • Sheila Savill